Sydney, Dec 19, 2006 (ABN Newswire) - Metabolic Pharmaceuticals Limited (ASX: MBP) - Metabolic Completes Options Study for Obesity Drug: AOD9604 - Dr Roland Scollay, CEO; Boardroomradio is pleased to announce that Metabolic Pharmaceuticals Limited (ASX: MBP) has published an audio file. The following presentation "Metabolic Completes Options Study for Obesity Drug: AOD9604" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast.
The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Broadcaster: Metabolic Pharmaceuticals Limited (ASX: MBP)
Broadcast Title: Metabolic Completes Options Study for Obesity Drug: AOD9604
Broadcast Type: Audio stream
View the Audio stream for Metabolic Pharmaceuticals Limited (ASX: MBP) below.
http://www.brr.com.au/event/MBP/1281/17552/wmp/221.242.254.150/?
PodCast Link:
About Boardroom Media
Boardroom.Media is a new breed of media company that's equal parts publisher, content producer, and streaming media technology business. With a strong footing in capital markets, professional services and asset management, the company has been a leading provider of multimedia communication solutions for corporate Australia for more than a decade.
